Ciltacabtagene autoleucel (Carvykti)

cilta-cetagene autoleucel · Janssen Biotech, Inc. and Legend Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ciltacabtagene autoleucel (Carvykti), covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma [Phase 3]

See pricing